0J6Z Stock Chart & Stats
$394.82
-$7.42(-1.89%)
At close: 4:00 PM EDT
$394.82
-$7.42(-1.89%)
Day’s Range― - ―
52-Week Range$162.00 - $436.26
Previous CloseN/A
Volume347.00
Average Volume (3M)373.00
Market Cap
$48.22B
Enterprise Value$62.43K
Total Cash (Recent Filing)$23.87B
Total Debt (Recent Filing)$14.25B
Price to Earnings (P/E)37.7
Beta0.44
Next Earnings
Nov 06, 2026Next Dividend Ex-DateN/A
Dividend Yield0.87%
Share Statistics
EPS (TTM)10.65
Shares Outstanding120,080,310
10 Day Avg. Volume300
30 Day Avg. Volume373
Financial Highlights & Ratios
PEG Ratio-18.55
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$429.86Price Target Upside8.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
EPS Forecast (FY)9.15
Revenue Forecast (FY)$162.51B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue expansion indicates continued demand for Humana’s insurance and healthcare services, supporting scale across its Medicare-focused platform. A growing revenue base can improve operating leverage and provide resources to invest in care coordination, member engagement, and future growth.
Cost ReductionMeasured cost-ratio improvement demonstrates that operating-model changes are translating into tangible efficiency gains. If maintained, lower administrative costs can provide durable support for margins, offset medical-cost pressure, and strengthen Humana’s ability to compete through benefits and service.
Medicaid ExpansionThe Illinois contract expands Humana’s presence in a government-backed healthcare market and broadens its membership platform beyond Medicare Advantage. A statewide award can create a durable growth channel while leveraging existing care-management capabilities and increasing diversification of government-program revenue.
Bears Say
Compressed ProfitabilityVery thin current margins leave limited protection if medical, pharmacy, or administrative costs rise faster than premiums. The sharp decline from earlier profitability also reduces earnings quality and makes future margin recovery dependent on sustained execution rather than simply continued revenue growth.
Drug Cost PressureElevated and rising prescription-drug costs directly pressure underwriting margins in Medicare and Part D coverage. Unless pricing, formulary management, rebates, or care programs offset the trend, persistent drug inflation can constrain profitability and make the path to sustainable margins more difficult.
Membership DisruptionLarge plan exits create a meaningful disruption to membership scale, retention, and risk mix. Even with recapture efforts, the historical rate implies that many affected members may not remain with Humana, potentially weakening revenue continuity and complicating margin planning over the next several quarters.
Humana News
0J6Z FAQ
What was Humana Inc’s price range in the past 12 months?
Humana Inc lowest share price was $162.00 and its highest was $436.26 in the past 12 months.
What is Humana Inc’s market cap?
Humana Inc’s market cap is $48.22B.
When is Humana Inc’s upcoming earnings report date?
Humana Inc’s upcoming earnings report date is Nov 06, 2026 which is in 60 days.
How were Humana Inc’s earnings last quarter?
Humana Inc released its earnings results on Jul 29, 2026. The company reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.268 by $0.342.
Is Humana Inc overvalued?
According to Wall Street analysts Humana Inc’s price is currently Undervalued.
Does Humana Inc pay dividends?
Humana Inc pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 0.87%. See more information on Humana Inc dividends here
What is Humana Inc’s EPS estimate?
Humana Inc’s EPS estimate is -1.
How many shares outstanding does Humana Inc have?
Humana Inc has 120,080,310 shares outstanding.
What happened to Humana Inc’s price movement after its last earnings report?
Humana Inc reported an EPS of $7.61 in its last earnings report, beating expectations of $7.268. Following the earnings report the stock price went down -6.8%.
Which hedge fund is a major shareholder of Humana Inc?
Currently, no hedge funds are holding shares in GB:0J6Z
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$429.86 (8.88% Upside)
$429.86 (8.88% Upside)
Blogger Sentiment
Bullish
GB:0J6Z Sentiment 73%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.55%
12-Months-Change
Fundamentals
Return on Equity
0.87%
Trailing 12-Months
Asset Growth
13.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Humana Inc
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
0J6Z Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally constructive operational and strategic progress narrative: clear cost-reduction execution (120 bps Y/Y improvement in Q2 operating cost ratio and expected ~150 bps full-year), tangible improvement in key Stars-related measures (outperforming historical CAGR on most selected metrics and ~5% better quality improvement rate for BY '29 measures), balance-sheet moves (Gentiva divestiture ~ $900M and $1.5B P-Cap facilities) and a new statewide Medicaid win. However, material risks remain — notably elevated and rising drug trend, dependence on membership mix for margin realization, plan-exit disruption (~600k members), elevated reserves/IBNR, and Stars/ policy uncertainty — which temper the outlook. On balance, the highlights (execution, cost savings, Stars operational progress, capital actions) outweigh the lowlights (policy uncertainty, drug trend, membership disruption), producing a cautiously positive sentiment.View all GB:0J6Z earnings summaries0J6Z Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income

0J6Z Stock 12 Month Forecast
Average Price Target
$429.86
▲(8.88% Upside)










